Dicerna Pharmaceuticals, Inc.
Therapeutic inhibition of lactate dehydrogenase and agents therefor
Last updated:
Abstract:
This invention relates to compounds, compositions, and methods useful for reducing lactate dehydrogenase target RNA and protein levels via use of ds RNAs, e.g., Dicer substrate siRNA (DsiRNA) agents.
Status:
Grant
Type:
Utility
Filling date:
1 Jul 2020
Issue date:
14 Jun 2022